Author: JPA Health

/C O R R E C T I O N — Pegasus/PBN Pharmacal/

May 20, 2026
Liavium®-CA1 (pregabalin chewable tablets) Receives FDA Conditional Approval, Redefining Canine Neuropathic Pain Care

May 18, 2026

/C O R R E C T I O N — Pegasus/PBN Pharmacal/